The European Parliament says the coronavirus pandemic has exposed the hazards of the EU’s reliance on third countries for medicines supply and has proposed that its vulnerability to drug shortages should be addressed by offering pharmaceutical companies incentives to bring some manufacturing back to Europe.
“Priority needs to be given to boosting domestic production of essential and strategic medicines as currently 40% of medicines marketed...








